ITHAX Acquisition Corp. (NASDAQ:ITHX) announced this morning it has secured an additional $20 million in funding for a total PIPE size of approximately $70 million to finance its combination with technology-first travel marketplace company Mondee.
At $10.00 per share, this additional all-equity funding is driven by two unnamed financial investors, which increases the aggregate gross proceeds to the combined company from the PIPE transactions from $50 million to $70 million. As a point of reference, this transaction has a minimum cash closing condition of $150 million.
ITHAX brings about $241.5 million into the deal from its current trust supplemented by the now $70 million PIPE. The original $50 million PIPE drew investments from funds affiliated with Morgan Stanley Investment Management, ARCPE, Origami, and strategic investors including Travco and Entertainment Benefits.
The combined company is expected to be traded on the Nasdaq under the ticker symbol “MOND” once the deal is completed in the first half of 2022.
ITHAX announced its $842 million combination with Mondee on December 20. The Silicon Valley-based company delivers an operating platform, modern ecosystem, and segment-specific content for the gig economy, remote workers, and travelers, mostly in the leisure segment of the travel market.
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...